Correlation Between Cannabis Sativa and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cannabis Sativa and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabis Sativa and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabis Sativa and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Cannabis Sativa and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabis Sativa with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabis Sativa and Corbus Pharmaceuticals.
Diversification Opportunities for Cannabis Sativa and Corbus Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cannabis and Corbus is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cannabis Sativa and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Cannabis Sativa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabis Sativa are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Cannabis Sativa i.e., Cannabis Sativa and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cannabis Sativa and Corbus Pharmaceuticals
Given the investment horizon of 90 days Cannabis Sativa is expected to generate 1.2 times less return on investment than Corbus Pharmaceuticals. In addition to that, Cannabis Sativa is 1.04 times more volatile than Corbus Pharmaceuticals Holding. It trades about 0.05 of its total potential returns per unit of risk. Corbus Pharmaceuticals Holding is currently generating about 0.06 per unit of volatility. If you would invest 387.00 in Corbus Pharmaceuticals Holding on August 26, 2024 and sell it today you would earn a total of 1,360 from holding Corbus Pharmaceuticals Holding or generate 351.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cannabis Sativa vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| Cannabis Sativa |
| Corbus Pharmaceuticals |
Cannabis Sativa and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cannabis Sativa and Corbus Pharmaceuticals
The main advantage of trading using opposite Cannabis Sativa and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabis Sativa position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| Cannabis Sativa vs. Embotelladora Andina SA | Cannabis Sativa vs. Signet International Holdings | Cannabis Sativa vs. National Beverage Corp | Cannabis Sativa vs. PT Astra International |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets |